Effect of combination antiretroviral therapy on Chinese rhesus macaques of simian immunodeficiency virus infection

AIDS Research and Human Retroviruses

Volumn 29, Issue 11, 2013, Pages 1465-1474

  Ling, Binhua ^a,b   Rogers, Linda ^a   Johnson, Ann Marie ^a   Piatak, Michael ^c   Lifson, Jeffrey ^c   Veazey, Ronald S ^a,b  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; EMTRICITABINE; INTEGRASE INHIBITOR; L 870812; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINESE RHESUS MACAQUE; COLON; COMBINATION ANTIRETROVIRAL TREATMENT; CONTROLLED STUDY; INTESTINE MUCOSA; JEJUNUM; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL CLEARANCE; VIRUS LOAD;

ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE MODELS, ANIMAL; DNA, VIRAL; MACACA MULATTA; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 84886699499     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0378     Document Type: Article

References (37)

1. Chun TW and Fauci AS: HIV reservoirs: Pathogenesis and obstacles to viral eradication and cure. AIDS 2012; 26(10): 1261-1268.
2. Deeks SG, Autran B, Berkhout B, et al.: Towards an HIV cure: A global scientific strategy. Nature Rev Immunol 2012; 12: 607-614.
3. Chun TW, Nickle DC, Justement JS, et al.: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008; 197(5): 714-720.
4. North TW, Higgins J, Deere JD, et al.: Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol 2010; 84(6): 2913-2922.
5. Tsai CC, Follis KE, Sabo A, et al.: Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995; 270(5239): 1197-1199.
6. Tsai CC, Follis KE, Beck TW, Sabo A, Bischofberger N, and Dailey PJ: Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques. AIDS Res Hum Retroviruses 1997; 13(8): 707-712.
7. Brandin E, Thorstensson R, Bonhoeffer S, and Albert J: Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy. J Virol 2006; 80(19): 9861-9864.
8. Boyer JD, Kumar S, Robinson T, et al.: Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response. J Med Primatol 2006; 35(4-5): 202-209.
9. Lewis MG, Norelli S, Collins M, et al.: Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: A basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. Retrovirology 2010; 7(1): 21.
10. Verhoeven D, Sankaran S, Silvey M, and Dandekar S: Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4 + T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J Virol 2008; 82(8): 4016-4027.
11. Dinoso JB, Rabi SA, Blankson JN, et al.: SIV-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 2009; 83: 9247-9257.
12. Kearney M, Spindler J, Shao W, et al.: Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy. J Virol 2011; 85(2): 1067-1076.
13. Ling B, Veazey RS, Luckay A, et al.: SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 2002; 16(11): 1489-1496.
14. Marthas ML, Lu D, Penedo MC, Hendrickx AG, and Miller CJ: Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: Transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses 2001; 17(15): 1455-1466.
15. Elbim C, Monceaux V, Francois S, Hurtrel B, Gougerot-Pocidalo MA, and Estaquier J: Increased neutrophil apoptosis in chronically SIV-infected macaques. Retrovirology 2009; 6: 29.
16. Ling B, Mohan M, Lackner AA, et al.: The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection. J Infect Dis 2010; 202(12): 1846-1854.
17. Ling B, Veazey RS, Hart M, et al.: Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression. AIDS 2007; 21(18): 2377-2385.
18. Reimann KA, Parker RA, Seaman MS, et al.: Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 2005; 79(14): 8878-8885.
19. Malet I, Calvez V, and Marcelin AG: The future of integrase inhibitors of HIV-1. Curr Opin Virol 2012; 2: 580-587.
20. Vallejo A, Gutierrez C, Hernandez-Novoa B, et al.: The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients. AIDS 2012; 26(15): 1885-1894.
21. Buzon MJ, Massanella M, Llibre JM, et al.: HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med 2010; 16(4): 460-465.
22. Cline AN, Bess JW, Piatak M Jr, and Lifson JD: Highly sensitive SIV plasma viral load assay: Practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 2005; 34(5-6): 303-312.
23. Paiardini M, Cervasi B, Reyes-Aviles E, et al.: Low levels of SIV infection in sooty mangabey central memory CD(4)( +) T cells are associated with limited CCR5 expression. Nat Med 2011; 17(7): 830-836.
24. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, and Vullo V: HIV-associated immune activation: From bench to bedside. AIDS Res Hum Retroviruses 2011; 27(4): 355-364.
25. Belmonte L, Olmos M, Fanin A, et al.: The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART. AIDS 2007; 21(15): 2106-2108.
26. Poles MA, Boscardin WJ, Elliott J, et al.: Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr 2006; 43(1): 65-68.
27. Queen SE, Mears BM, Kelly KM, et al.: Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques. J Virol 2011; 85(17): 9167-9175.
28. Okoye A, Meier-Schellersheim M, Brenchley JM, et al.: Progressive CD4 + central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007; 204(9): 2171-2185.
29. Verhoeven D, Sankaran S, and Dandekar S: Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy. J Med Primatol 2007; 36(4- 5): 219-227.
30. He H, Nehete PN, Nehete B, et al.: Functional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaques. PLoS One 2011; 6(5): e19607.
31. Okoye AA, Rohankhedkar M, Abana C, et al.: Naive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection. J Exp Med 2012; 209(4): 641-651.
32. Van Rompay KK, Trott KA, Jayashankar K, et al.: Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. Retrovirology 2012; 9: 57.
33. Chomont N, El-Far M, Ancuta P, et al.: HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15(8): 893-900.
34. Chomont N, DaFonseca S, Vandergeeten C, Ancuta P, and Sekaly RP: Maintenance of CD4+ T-cell memory and HIV persistence: Keeping memory, keeping HIV. Curr Opin HIV AIDS 2011; 6(1): 30-36.
35. Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, and Siliciano RF: Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 2007; 5(2): 95-106.
36. Nixon DE and Landay AL: Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 2010; 5(6): 498-503.
37. Plaeger SF, Collins BS, Musib R, Deeks SG, Read S, and Embry A: Immune activation in the pathogenesis of treated chronic HIV disease: A workshop summary. AIDS Res Hum Retroviruses 2012; 28(5): 469-477.